Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Alberta

$17,500.00

Association of powdered milk with reduced progression of MAFLD in animals

FY 2022-23

Summary
Metabolism-Associated Fatty Liver Disease (MAFLD) is a common metabolic disorder affecting a quarter of the population. To put this into numbers, in 2019 MAFLD was prevalent in almost 8 million people and is estimated to increase by 20% by 2030. The main risk factors for this disease are obesity and type 2 diabetes (T2D); both of which are global epidemics. MAFLD is concurrently a risk factor for T2D and obesity, highlighting the importance of effective treatment protocols as there are no current national models of care for this disease. MAFLD and its resulting complications are the second leading cause of liver transplantation in North America, slightly trailing behind hepatitis C virus infection, and is expected to become the leading cause shortly. Current treatments include altering diet and exercise habits to promote healthy living as there are no approved pharmaceuticals. Our lab’s previous research in mice uncovered that feeding a low dose (equivalent to 0.6 servings) of regular fat milk resulted in the normalization of hepatic steatosis and reduced serum triglyceride, thus displaying a reduced progression of MAFLD. The aim of my research is to discover whether powdered milk, used to increase nutritional value of processed foods, will retain the beneficial effects. The experimental plan associated includes a mouse model fed a high fat/high sucrose diet to induce insulin resistance and hepatic steatosis. The mice will then be placed on either a non-fat powdered milk treatment or a regular fat powdered milk treatment. The subsequent steps include tissue collection and analysis of hepatic lipid metabolism within the experimental groups to determine if the treatment groups altered the progression of MAFLD and comparison to previous studies on liquid milk treatment.
Program
Master's Award: Canada Graduate Scholarships
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
486514
Name
Berg Emily J
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Association of powdered milk with reduced progression of MAFLD in animals
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Clinical; Diet; Disease; Hepatic; Homeostasis; Insulin; Lipid; Metabolic; Physiology; Progression
Abstract
Metabolism-Associated Fatty Liver Disease (MAFLD) is a common metabolic disorder affecting a quarter of the population. To put this into numbers, in 2019 MAFLD was prevalent in almost 8 million people and is estimated to increase by 20% by 2030. The main risk factors for this disease are obesity and type 2 diabetes (T2D); both of which are global epidemics. MAFLD is concurrently a risk factor for T2D and obesity, highlighting the importance of effective treatment protocols as there are no current national models of care for this disease. MAFLD and its resulting complications are the second leading cause of liver transplantation in North America, slightly trailing behind hepatitis C virus infection, and is expected to become the leading cause shortly. Current treatments include altering diet and exercise habits to promote healthy living as there are no approved pharmaceuticals. Our lab’s previous research in mice uncovered that feeding a low dose (equivalent to 0.6 servings) of regular fat milk resulted in the normalization of hepatic steatosis and reduced serum triglyceride, thus displaying a reduced progression of MAFLD. The aim of my research is to discover whether powdered milk, used to increase nutritional value of processed foods, will retain the beneficial effects. The experimental plan associated includes a mouse model fed a high fat/high sucrose diet to induce insulin resistance and hepatic steatosis. The mice will then be placed on either a non-fat powdered milk treatment or a regular fat powdered milk treatment. The subsequent steps include tissue collection and analysis of hepatic lipid metabolism within the experimental groups to determine if the treatment groups altered the progression of MAFLD and comparison to previous studies on liquid milk treatment.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Berg, Emily J
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~